EHS Due Diligence for Medical Industrial Production

Customer:
DSS+ and Gyrus Capital

Project:
EHS Due Diligence for the LivaNova Acquisition (Sorin Group)

Period:
2021

Scope:
AR19 has joined Gyrus Capital's DSS+ team for an Environmental and Health & Safety Due Diligence review of the acquisition of LivaNova, a leading medical technology and innovation company, for the divestment of its heart valve business.

Approach (by lines of work):

• Initial document analysis and coordination with the multidisciplinary Due Diligence team

• In-depth interviews;

• Inspection of the multi-company areas of Livanova Site Management and of the production areas of Livanova HV in Saluggia (TO);

• Identify existing gaps and quantify liabilities to support the negotiation.